What does this test accomplish?
An antigen-capture (sandwich) ELISA detects a particular viral protein, called an antigen, in a specimen. The wells are already coated and blocked with capture antibodies that recognize fictional V-17 antigen. Students do not need to add those antibodies in this version.
After a specimen is added, captured antigen stays in the well through washing. A second, HRP-linked antibody recognizes that captured antigen. Its enzyme converts TMB substrate into a colored product, which the plate reader measures.
Investigation: Compare the early (T₀) and later (T₁) specimens. Is there evidence of more detectable V-17 antigen in the later specimen, and did the controls behave as expected?
Not tested: This ELISA does not measure viral attachment, entry, infectious titer, or whether infectious virus was produced. A positive antigen signal cannot establish those conclusions.
Type of evidence: This version is comparative/semiquantitative. Without a multi-point calibration curve, you cannot calculate the unknown antigen concentration in ng/mL from the absorbance.
What each reagent actually does
| Material | What it contains or does | Why we use it |
| Pre-coated, blocked plate | Capture antibodies are already attached to the well surface. Blocking reduces nonspecific binding. | Retains V-17 antigen if it is present in the sample. |
| Negative control (NEG) | Sample with no V-17 antigen. | Shows background signal. It should read low if the assay is working. |
| Positive control (POS) | Known V-17 antigen sample (20 ng/mL in this fictional model). | Checks whether the capture, antibody and color-detection system can produce a clear signal. |
| Early (T₀) specimen | Unknown early-time V-17 specimen. | Provides a baseline antigen signal for comparison. |
| Later (T₁) specimen | Unknown later-time V-17 specimen. | Tests whether more antigen is detectable later. |
| HRP-linked detection antibody | An antibody that binds captured V-17 antigen and carries the enzyme horseradish peroxidase (HRP). | Links antigen presence to an enzyme-driven color reaction. |
| Wash buffer | Simulated by the Wash plate control, not a shelf bottle. | Removes unbound sample and antibody. Insufficient washing can raise background. |
| TMB substrate | A chromogenic HRP substrate; initially nearly colorless. | HRP converts it to a blue product during development. |
| Stop solution | An acidic stopping reagent in the simulation. | Stops the enzyme reaction and changes developed blue product to yellow for A₄₅₀ measurement. |
Important: The colored caps and labels distinguish stock containers. They do not imply that all reagents are visibly colored in real life.
Why the procedure follows this order
- Add samples (100 µL per well). Place negative and positive controls in A1–A4, early specimen in B1–B2, and later specimen in B3–B4. Each pair is a duplicate.
- Incubate, then wash (3 simulated cycles). Give antigen time to bind capture antibodies, then remove unbound material.
- Add HRP-linked detection antibody (50 µL). It binds captured viral antigen; incubate, then wash 3 simulated cycles to remove unbound antibody.
- Add TMB (100 µL). Activate Develop TMB. The enzyme reaction may turn wells blue, depending on how much HRP remains.
- Add stop solution (50 µL). Developed blue signal becomes yellow. Read the plate at 450 nm.
- Record the evidence. Copy A₄₅₀ values for every well into your physical lab manual, calculate duplicate means, and assess controls before concluding anything about T₀ and T₁.
Why duplicates? Similar readings make the data more credible. Large differences between paired wells suggest handling variation or other problems.
The volumes and processing steps in this app are teaching-model parameters, not directions for an actual commercial kit.
How to interpret the plate
The reader reports A₄₅₀ (absorbance at 450 nm). For a properly run HRP/TMB assay, a stronger yellow color generally corresponds to higher absorbance, reflecting more bound enzyme-linked detection antibody and thus more detected antigen within the assay's working range.
| Observation | Interpretation |
| Negative control low; positive control high; duplicates agree | Controls support interpreting sample differences. |
| T₁ mean higher than T₀ mean, with valid controls | More V-17 antigen was detected in the later specimen. This does not prove infectious-virus production. |
| T₀ and T₁ means similar | No clear increase is detected by this assay under these conditions; do not claim the virus is absent. |
| Negative control unexpectedly high | Possible excess background, incomplete washing, carryover, or misplaced reagent. Sample findings may be unreliable. |
| Positive control unexpectedly low | Possible missed reagent, insufficient incubation, poor color development, or pipetting problem. Sample findings may be unreliable. |
| Duplicate wells very different | Question precision or handling. Investigate before accepting the mean. |
First calculate: Mean A₄₅₀ = (well 1 + well 2) / 2 for each pair. Then compare the unknown means with both controls. You may also calculate the difference T₁ − T₀.
Simulator-only quality guidelines: Negative mean < 0.18; positive mean > 0.65; pair difference < 0.20. These are not clinical thresholds or universal ELISA cutoffs.
When an assay doesn't work
- High background across wells: Try tracing whether wash steps were omitted, reagents carried over on a reused tip, or the wrong sample entered a control well.
- Weak positive control: Check pipette volume, whether detection antibody was added, whether the plate was incubated, and whether TMB was developed.
- Inconsistent duplicates: Compare well-specific additions, pipette settings, and tips rather than relying only on the average.
- Wrong reagent order: Color can be absent or misleading. The software records the sequence in its log; use it as a clue, not an answer key.
Use your manual to write a claim, evidence, and reasoning statement. Include numerical readings and discuss whether the controls make your interpretation defensible.